Price: $399.99
Access: 30 Months
Deliverables: 1,672 Board-Style Questions, 17 Hours of Video Lecture, 100 AAPA Category 1 CME Credits
The NCCPA’s Longitudinal Assessment (PANRE-LA) has transformed the way Physician Assistants maintain their certification. Gone are the days of a single, high-stakes exam every ten years. However, with the new format comes a set of specific, rigid rules regarding the "12-quarter" window that every PA in their recertification cycle must master.
If you are currently in Year 6 of your cycle, you are approaching the critical application window. Here is the breakdown of the 12-quarter process and how it affects your path to recertification.
The 12-Quarter Framework
The PANRE-LA is administered over a total of 12 assessment quarters, spanning three years (Years 7, 8, and 9 of your maintenance cycle). Each quarter, you are presented with 25 questions.
- Scoring on the Best 8: While the process spans 12 quarters, your final pass/fail decision is based on your performance in 8 quarters.
- The "Best 8" Rule: If you participate in more than 8 quarters, the NCCPA automatically drops your lowest-performing quarters and recalculates your score based on your best 8.
- Mandatory Participation: You must participate in at least one quarter during the first year of your window (Year 7) and at least one quarter during the second year (Year 8). Failure to do so results in removal from the PANRE-LA program.
- Timing: Each quarter is open for approximately 10 weeks. You have 5 minutes per question. Once you answer 25 questions or the quarter ends, that quarter is complete.
Passing the Assessment
You can finish the PANRE-LA in as few as 8 quarters if you meet or exceed the passing standard. Once you reach that threshold, you are notified that you have passed, and you no longer need to participate in subsequent quarters.
If you do not meet the passing standard by the end of the 12th quarter, you are exited from the longitudinal program and must take the traditional PANRE at a testing center. There are no "retakes" for the PANRE-LA itself.
Maximizing Your CME During the Process
While the PANRE-LA is an "open-book" format, the 5-minute time limit per question requires a baseline of quick clinical recall. Our PANRE Review Course is specifically designed to cover the NCCPA Blueprint topics that appear most frequently.
When you purchase our PANRE CME Package, you receive 100 AAPA Category 1 Self-Assessment CME credits. Because these are self-assessment credits, the NCCPA applies an additional 50% weighting, meaning these 100 hours count as 150 credits toward your maintenance requirements.
Additionally, we offer CME with Amazon and Apple Gift Card add-ons. You can add a gift card ranging from $100 to $1500 to your purchase, allowing you to use your employer's CME budget for both high-yield education and necessary clinical tools.
Clinical Assessment
The following vignettes are designed to test your clinical knowledge in a format similar to the PANRE-LA.
Question 1
Your patient is a 64-year-old male with a history of hypertension and tobacco use who presents to the emergency department with substernal chest pressure radiating to the left jaw. The pain started 45 minutes ago while he was mowing the lawn. Vital signs are HR 98, BP 155/92, SaO2 96% on room air. The EKG shows 3mm ST-segment elevation in leads II, III, and aVF.
Which of the following is the most appropriate next step in management?
A. Immediate cardiac catheterization and percutaneous coronary intervention (PCI)
B. Administration of intravenous thrombolytics
C. Exercise stress testing
D. Observation and serial troponins
Explanation: A. Immediate cardiac catheterization and percutaneous coronary intervention (PCI) is the correct choice. The patient is presenting with an acute inferior ST-elevation myocardial infarction (STEMI). The standard of care is emergent reperfusion, preferably via PCI if available within 90 minutes. Intravenous thrombolytics (B) are reserved for cases where PCI is not available within a 120-minute window. Exercise stress testing (C) is contraindicated in the setting of an acute MI. Observation (D) is inappropriate for a confirmed STEMI.
Question 2
Your patient is a 28-year-old female who presents with a chronic skin rash on her elbows and knees. She reports the rash is itchy and occasionally bleeds when she scratches it. On physical examination, you observe well-demarcated, erythematous plaques with thick, silvery scales. When you attempt to remove a scale, pinpoint bleeding occurs.
What is the most likely diagnosis?
A. Psoriasis
B. Atopic Dermatitis
C. Tinea Corporis
D. Lichen Planus
Explanation: A. Psoriasis is the correct diagnosis. The clinical description of well-demarcated erythematous plaques with silvery scales on extensor surfaces (elbows, knees) is classic for plaque psoriasis. The pinpoint bleeding noted upon scale removal is known as the Auspitz sign. Atopic Dermatitis (B) typically affects flexor surfaces and presents with ill-defined eczematous lesions. Tinea Corporis (C) presents as annular lesions with central clearing. Lichen Planus (D) presents as purple, polygonal, pruritic, planar papules, typically on the wrists or ankles.
Question 3
Your patient is a 72-year-old male brought in by his wife for "shaking." She notes he has become increasingly slow in his movements and has difficulty getting out of chairs. On examination, you note a resting "pill-rolling" tremor of the right hand, bradykinesia, and a shuffling gait with decreased arm swing.
Which of the following medications is the most effective first-line treatment for this patient's symptoms?
A. Levodopa-Carbidopa
B. Donepezil
C. Amitriptyline
D. Memantine
Explanation: A. Levodopa-Carbidopa is the correct choice. The patient presents with the classic triad of Parkinson's Disease: tremor, bradykinesia, and postural instability (shuffling gait). Levodopa-Carbidopa is the most effective treatment for managing the motor symptoms of the disease. Donepezil (B) and Memantine (D) are used in the management of Alzheimer’s dementia, not the primary motor symptoms of Parkinson's. Amitriptyline (C) is a tricyclic antidepressant and is not a first-line treatment for Parkinsonian motor symptoms.
Prepare for the NCCPA Blueprint
Our Pharmacology Review CME and PANRE packages cover all 13 organ systems of the NCCPA Blueprint, including Cardiology, Dermatology, and Neurology. Whether you are choosing the PANRE-LA or the traditional PANRE, stay ahead of the 12-quarter deadline by refreshing your clinical knowledge today.